Suppr超能文献

术前血糖控制不佳对行根治性子宫切除术的宫颈癌患者结局的影响。

Impact of Poor Preoperative Glycemic Control on Outcomes among Patients with Cervical Cancer Undergoing a Radical Hysterectomy.

机构信息

Operating Room, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Operating Room, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China,

出版信息

Oncol Res Treat. 2020;43(1-2):10-18. doi: 10.1159/000502911. Epub 2019 Nov 20.

Abstract

BACKGROUND

The impact of preoperative glycemic control on the survival outcomes of patients undergoing a radical hysterectomy (RH) for cervical cancer has not been investigated.

PATIENTS AND METHODS

We reviewed patients who underwent a type III RH for cervical cancer between January 2004 and June 2011 in our institution.

RESULTS

A total of 431 patients were included and 83 (19.3%) were diagnosed with diabetes mellitus (DM). Poorly controlled DM (preoperative hemoglobin A1c [HbA1c] ≥7.0%) was observed in 49 (59.0%) diabetic patients. Compared to patients without DM and diabetic patients with good glycemic control (preoperative HbA1c <7.0%), diabetic patients with poor glycemic control had significantly higher risks of tumor recurrence, cervical cancer-specific death, and overall death. In multivariate analysis, DM with poor glycemic control independently predicted recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). We excluded patients without DM and performed a sensitivity analysis. When HbA1c levels were treated as a dichotomous variable, preoperative HbA1c ≥7.0% was independently associated with RFS, CSS, and OS. When HbA1c level was treated as a continuous variable, it remained an independent predictor of RFS, CSS, and OS.

CONCLUSION

DM with poor glycemic control prior to RH was significantly associated with an increased risk of recurrence and mortality in cervical cancer patients. These results underscore the importance of intensive glycemic control and close follow-up for diabetic patients.

摘要

背景

术前血糖控制对接受根治性子宫切除术(RH)治疗宫颈癌患者的生存结局的影响尚未得到研究。

患者和方法

我们回顾了 2004 年 1 月至 2011 年 6 月期间在我院接受 III 型 RH 治疗的宫颈癌患者。

结果

共纳入 431 例患者,其中 83 例(19.3%)诊断为糖尿病(DM)。49 例(59.0%)糖尿病患者血糖控制不佳(术前糖化血红蛋白[HbA1c]≥7.0%)。与无糖尿病和血糖控制良好(术前 HbA1c<7.0%)的糖尿病患者相比,血糖控制不佳的糖尿病患者肿瘤复发、宫颈癌特异性死亡和总死亡的风险显著更高。多因素分析显示,血糖控制不佳的 DM 独立预测无复发生存(RFS)、癌症特异性生存(CSS)和总生存(OS)。我们排除了无 DM 的患者并进行了敏感性分析。当 HbA1c 水平作为二分类变量时,术前 HbA1c≥7.0%与 RFS、CSS 和 OS 独立相关。当 HbA1c 水平作为连续变量时,它仍然是 RFS、CSS 和 OS 的独立预测因子。

结论

RH 前血糖控制不佳的 DM 与宫颈癌患者复发和死亡风险增加显著相关。这些结果强调了对糖尿病患者进行强化血糖控制和密切随访的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验